Imatib 400mg
Available Dosages
| SKU | 531 |
|---|---|
| Generic For | Imatib |
| Strength | 400mg |
| Active Ingredient | Imatinib |
Out Of Stock
Imatib 400mg (Imatinib) for CML Leukemia
Imatib 400 mg is a medication that targets proteins in cancer cells and stops the growth of cancer (abnormal cells). Its active component Imatinib interferes with the growth of cancer forming cells. Imatinib is a tyrosine kinase inhibitor, which inhibits the growth of abnormal cells in certain types of cancers. The medicine is prescribed for certain types of leukaemia (blood cancers), skin cancer, bone marrow disorders, or certain tumours of the abdomen and digestive cancer. You can get this medicinal product only on a prescription of a physician.
What is Imatib 400mg used for?
Imatib is indicated for the following:
- Gastrointestinal stromal tumours
- Hypereosinophilic syndrome
- Philadelphia chromosome-positive
- Chronic eosinophilic leukaemia
- Chronic myeloid leukaemia in chronic phase in children and adults
How does Imatib work?
Imatib is an anti-cancer drug, which works by inhibiting kinases that may be produced by malignant cell lines.
Effects of grape juice on Imatib
The risk of side effects is raised by grapefruit juice; therefore the concurrent use of Imatib with grape juice should be avoided.
What are the side effects of Imatib?
- Central nervous system disorders- weakness, somnolence, fatigue, dizziness, headache
- Gastrointestinal disorders- anorexia, diarrhoea, constipation, abdominal pain, hepatotoxicity, dyspepsia, vomiting, nausea
- Endoskeletal issues- hypothyroidism, decrease growth in children
- Metabolic disorders- weight gain
- Haematological issues neutropenia, bleeding, thrombocytopenia
- EENT disorders- blurred vision, nasopharyngitis, epistaxis
- Dermatological issues- skin rash, pruritus, petechiae
- Musculoskeletal issues- muscle cramps, myalgia, arthralgia, skeletal pain, muscle cramps
- F and E disorders- Edema, hypokalemia
- Miscellaneous issues- fever, tumour lysis syndrome, night sweats the fever
- Respiratory system disorders- pneumonia, dyspnea, cough
What medications interact with Imatib?
- Blood levels increased by concurrent use of drugs like itraconazole, atazanavir, nefazodone, saquinavir, nelfinavir, voriconazole, clarithromycin, telithromycin, indinavir, ritonavir, or ketoconazole.
- Blood levels and effects may decrease by the use of phenytoin, carbamazepine, rifabutin, phenobarbital, dexamethasone. The concurrent use may increase the dose of Imatib by 50%.
- Imatib may increase blood levels of simvastatin.
How should Imatib be used?
- The anti-cancer treatment is for various conditions and because of this, the dose regimen will vary from patient to patient, depending on the health conditions and various other factors. Gastrointestinal stromal tumors, Chronic eosinophilic leukemia, Hypereosinophilic syndrome, Chronic myeloid leukemia in chronic phase, Philadelphia chromosome-positive, or any other condition, all required different dose regimen, and a patient must follow all the instruction of his/her physician. Make sure that you understand all the directions, how much to take, how often you need to take, and how long you take this medication. Please discuss, if you have any doubt about the usage of the medicine.
- Take medicine with food and a glass of full water to minimize gastrointestinal irritation. The recommended dose of Imatib is 400 mg daily for adult patients with chronic myeloid leukemia and CML accelerated phase/blast crisis.
- Do not increase or decrease the length of the treatment by yourself. Your health condition will not improve any faster, and your risk of developing adverse reactions increases.
When should Imatib not be used?
- Imatib is not suitable for patients with hypersensitivity.
- Pregnant women must not take the tablets as there is a potential for fetal harm.
- Notify nursing mothers for serious adverse reactions in nursing infants. Breast-feeding should be avoided during the treatment.
Exercise caution while taking this anti-cancer agent in the following conditions:
- Liver impairment
- Cardiac disorders
- Pediatrics
- Geriatrics
How long should Imatib be used?
Imatib Treatment should be continued as long as a patient continues to benefit or as prescribed by the physician.
Missed dose of Imatib
If you are taking Imatib 400 mg once daily and miss a dose, take the dose as soon as possible with a meal and a large glass of water. The missed dose should not be taken if the time to take the next dose is near. Do not take a double dose to make up for any missed dose.
What is Imatinib and what condition does it treat?
Imatinib is a targeted cancer therapy medication, marketed under brand names like Imatib 400mg, that belongs to a class of drugs called tyrosine kinase inhibitors. This prescription medicine treats several serious conditions including chronic myeloid leukemia (CML), acute lymphoblastic leukemia (Philadelphia chromosome-positive), gastrointestinal stromal tumors (GIST), and certain rare blood disorders. Imatinib works by blocking abnormal proteins that cause cancer cells to multiply uncontrollably. Healthcare providers prescribe this chemotherapy agent as part of long-term cancer management strategies, helping patients achieve remission and maintain disease control.
How does Imatinib work in the body?
Imatinib functions as a tyrosine kinase inhibitor, meaning it blocks specific enzymes responsible for cancer cell growth. In conditions like chronic myeloid leukemia, abnormal proteins signal cells to divide rapidly and uncontrollably. Imatib 400mg targets these faulty proteins at the molecular level, essentially switching off the signals that tell cancer cells to multiply. This targeted approach allows the medication to interfere with cancer progression while minimizing damage to healthy cells. Unlike traditional chemotherapy that attacks all rapidly dividing cells, this precision medicine focuses specifically on cancerous tissue, making it a cornerstone of modern oncology treatment.
How long does Imatib 400mg take to work?
Response time for Imatib 400mg varies depending on your specific condition and treatment goals. For chronic myeloid leukemia patients, initial blood count improvements may appear within four to twelve weeks, though achieving complete cytogenetic response typically takes three to six months of consistent therapy. Patients with gastrointestinal stromal tumors often notice tumor stabilization or reduction within two to four months on this tyrosine kinase inhibitor. Your oncologist will monitor progress through regular blood tests and imaging studies. Remember that imatinib therapy is generally long-term, and optimal results develop gradually as the medication continuously suppresses abnormal cell growth.
When and how should I take Imatib 400mg?
Take Imatib 400mg exactly as your oncologist prescribes, typically once daily with a large meal and full glass of water. Taking this tyrosine kinase inhibitor with food significantly reduces stomach irritation and improves absorption. Swallow tablets whole without crushing or breaking them. Most patients take their dose at the same time each day to maintain consistent imatinib levels in the bloodstream. If you miss a dose, take it as soon as you remember unless it's almost time for your next scheduled dose—never double up. Always follow your healthcare provider's specific instructions and attend all monitoring appointments for blood work and liver function tests.
Is Imatib 400mg safe for long-term use?
Imatib 400mg is specifically designed for extended therapy, with many patients taking this tyrosine kinase inhibitor for years to maintain disease control. Clinical studies demonstrate that long-term imatinib use effectively manages chronic myeloid leukemia and other conditions with acceptable safety profiles when properly monitored. Your oncology team will conduct regular blood tests to check liver function, kidney function, and blood counts throughout treatment. While some patients experience side effects initially, these often diminish over time as your body adjusts. The benefits of continued cancer control typically outweigh risks for most patients, though individual experiences vary based on overall health and response.
Can I take Imatib 400mg with other medicines?
Imatib 400mg can interact with numerous medications, so inform your healthcare provider about everything you take including prescriptions, over-the-counter drugs, and supplements. This tyrosine kinase inhibitor may interact significantly with blood thinners like warfarin, certain antibiotics, antifungals, heart medications, and herbal products like St. John's Wort. Some drugs increase imatinib levels causing more side effects, while others reduce effectiveness. Avoid grapefruit and grapefruit juice entirely as they interfere with how your body processes this cancer medication. Your pharmacist at PremiumRxDrugs can review your complete medication list for potential interactions when processing your prescription.
How does Imatib 400mg compare to similar medicines in its class?
Imatib 400mg contains imatinib, which was the first tyrosine kinase inhibitor approved for chronic myeloid leukemia and remains a gold-standard first-line treatment. While newer alternatives like dasatinib and nilotinib exist within the same drug class, imatinib offers proven long-term efficacy with extensive safety data spanning over two decades. These second-generation inhibitors work faster in some patients but may cause different side effects. Imatinib's established track record, cost-effectiveness as a generic option, and well-understood side effect profile make it the preferred initial therapy for many oncologists. Your cancer specialist chooses treatment based on disease characteristics, tolerance, and individual response.
Is the generic Imatinib as effective as branded versions?
Generic imatinib, including Imatib 400mg, contains the identical active ingredient as branded versions like Gleevec and delivers equivalent therapeutic results. Regulatory authorities in the USA, UK, Canada, and Australia require generic cancer medications to demonstrate bioequivalence, meaning they work in your body exactly like brand-name counterparts. Clinical evidence confirms that patients switching from branded to generic tyrosine kinase inhibitors maintain disease control without compromising treatment outcomes. The significant cost savings with generic imatinib make long-term cancer therapy more affordable without sacrificing quality. Generic versions undergo rigorous testing and must meet the same strict manufacturing standards as original branded medications.
Why do patients choose PremiumRxDrugs for Imatib 400mg?
Patients select PremiumRxDrugs for Imatib 400mg because of consistently competitive pricing on this essential tyrosine kinase inhibitor, making long-term cancer treatment more affordable. As a licensed international pharmacy trusted for more than ten years, we guarantee authentic manufacturer-sourced imatinib, eliminating concerns about counterfeit medications. Our straightforward prescription management system simplifies refills for ongoing therapy, while discreet packaging protects your privacy. With worldwide shipping to the USA, UK, Australia, Canada, and beyond, plus free shipping options, accessing your cancer medication becomes hassle-free. Our reputation for reliability and customer service excellence makes us a preferred choice for patients requiring continuous speciality pharmaceutical care.
What are the common side effects of Imatinib?
Common side effects of imatinib include nausea, vomiting, diarrhea, muscle cramps, and fatigue, which many patients experience especially during initial treatment weeks. This tyrosine kinase inhibitor frequently causes fluid retention leading to swelling around eyes, ankles, or hands, plus unexpected weight gain. Skin rashes, headaches, and joint pain occur regularly but usually remain manageable. Many patients notice these effects diminish as their body adjusts to the cancer medication. Less common but serious reactions include liver problems, severe fluid retention, bleeding issues, and low blood counts. Report unusual symptoms like yellowing skin, severe abdominal pain, unusual bruising, or persistent fever immediately to your healthcare provider.
Who should avoid taking Imatinib?
Pregnant or breastfeeding women should not take imatinib as this tyrosine kinase inhibitor can harm developing babies and passes into breast milk. Individuals with severe liver disease, uncontrolled heart failure, or known hypersensitivity to the medication should avoid this cancer therapy. Patients with compromised kidney function require careful dose adjustments and close monitoring. Those planning surgery may need temporary discontinuation due to bleeding risks. Children under certain ages may not be suitable candidates depending on their specific condition. Anyone with active infections, low blood counts, or history of gastrointestinal bleeding requires thorough evaluation before starting treatment. Your oncologist will assess your complete medical history to determine if imatinib therapy is appropriate.
Login
Sign Up
Login
Sign Up